Skip to content
Monday, May 23, 2022
HealthCare Africa Magazine

Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine

Africa Health & Wellness Expo ad
  • Home
  • TOPICS
    • INVESTMENTS & FUNDING
    • MERGERS & ACQUISITIONS
    • DISEASES UPDATES
    • HEALTHCARE DELIVERY
    • PHARMA MANUFACTURING
    • PEOPLE NEWS
    • CORONAVIRUS NEWS
    • REGULATORY & POLICY
  • THE MAGAZINE
    • About HealthCare Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • VIDEOS
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Sun Pharma to launch Brillo, a first in class oral lipid lowering drug
  • Globus Medical announces first surgeries using Excelsius3D
  • Humana, private equity firm launch 2nd primary care joint venture for Medicare patients
  • Covax wants urgent action to close vaccine equity gap
  • Health-tech Zuri Health secures US$1.3M in pre-seed round to expand operations across Africa
  • Bayer to end CAR T-cell therapies collaboration with Atara Biotherapeutics
  • WHO validates CONVIDECIA as 11th vaccine for COVID-19
  • India’s drug regulator approves Boehringer Ingelheim’s cardiac treatment
  • CCI approves Covidshield Technologies, Biocon Biologics merger
  • Aster DM flies higher with Skye Air drone partnership
You are here
  • Home
  • Switzerland

Tag: Switzerland

Novartis announces new organizational structure; targets cost-savings of US$1 Bn

8 April 20228 April 2022

SWITZERLAND –Novartis has announced a new organizational structure and operating model with the goal of achieving US$1 billion in cost savings by 2024, as well as changes in executive leadership…

Read More

Sandoz acquires UK-based drug delivery device firm Coalesce

17 March 202217 March 2022

SWITZERLAND – Sandoz, a Novartis division, has acquired Coalesce Product Development Limited, a medical and drug delivery device development company based in the United Kingdom. Sandoz has acquired Coalesce’s capabilities…

Read More

Novartis inks US$1.8 billion deal with Voyager for gene therapy vectors

9 March 20229 March 2022

SWITZERLAND – Voyager Therapeutics has secured a license option agreement in a potentially US$1.8 billion deal with Novartis. Novartis will be able to use the gene therapy company’s capsid discovery…

Read More

Aspen sells pharmaceutical brands worth US$120m to Swiss firm Acino

8 March 20228 March 2022

SOUTH AFRICA – South African pharmaceutical Aspen has finalized an agreement with Switzerland Acino Pharma AG for Acino to acquire six South African prescription medicines from Pharmacare Limited, a subsidiary…

Read More

Essential health services face continued disruption globally during COVID-19 pandemic

9 February 20229 February 2022

SWITZERLAND – According to the findings of the third round of the World Health Organization’s (WHO) Global Pulse Survey, Health systems are still facing significant challenges in providing essential health…

Read More

Private Equity firms mull co-bidding for Novartis generics arm

3 February 20223 February 2022

SWITZERLAND – Two private equity giants are discussing launching a joint bid for Novartis’ generics unit, Bloomberg has reported. Novartis announced last year that it was conducting a strategic review…

Read More

Roche to reexamine Huntington’s disease drug

20 January 202220 January 2022

SWITZERLAND – Roche has outlined a new clinical path forward for tominersen, a closely watched Huntington’s disease drug, ten months after disappointing Phase 3 study results appeared to spell the…

Read More

Roche launches its connected blood glucose monitoring system in Europe

13 January 202213 January 2022

SWITZERLAND – Roche has announced that its Cobas Pulse system is now available in select European countries that accept CE mark approval. Roche created the Cobas Pulse system to combine…

Read More

Novartis buys ocular gene therapy firm for US$1.5 billion

4 January 20224 January 2022

SWITZERLAND – Novartis has agreed to pay up to US$1.5 billion for Gyroscope Therapeutics, a U.K.-based ocular gene therapy company, as the pharmaceutical giant seeks to acquire smaller companies with…

Read More

Roche’s arthritis drug scores EMA approval for treating severe Covid-19

7 December 20217 December 2021

NETHERLANDS – The European Medicines Agency (EMA) has recommended extending the use of Roche’s RoActemra arthritis drug for adult COVID-19 patients receiving systemic steroid treatment and those requiring oxygen support…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

Africa Health & Wellness Expo ad

Popular Posts Recent Posts

AAR Healthcare unveils new ultra-modern 140-bed capacity hospital

Ghanaian startup Yemaachi secures US$3M seed funding to advance cancer research

Lilly announces the Institute for Genetic Medicine and US$700 million investment

FDA OK’s Quantum’s Epione robot for liver cancer

Africa’s journey to healthcare independence, as fueled by effects of the ongoing pandemic

Sun Pharma to launch Brillo, a first in class oral lipid lowering drug

Globus Medical announces first surgeries using Excelsius3D

Humana, private equity firm launch 2nd primary care joint venture for Medicare patients

Covax wants urgent action to close vaccine equity gap

Health-tech Zuri Health secures US$1.3M in pre-seed round to expand operations across Africa

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Biogen Cancer China COVAX Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS India Investments & Funding Japan Johnson & Johnson Kenya Malaria Manufacturing Merck Mergers & Acquisitions Moderna MOH Kenya Nigeria Novartis Pfizer Pharmaceuticals Roche Sanofi Science & Technology South Africa Switzerland Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Africa MagazineFollow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCare Africa Magazine
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

About 1 billion people globally denied access to assistive products: Report
https://t.co/XdBGynFqHM #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment @WHO @UNICEF

Reply on Twitter 1527549390788902913Retweet on Twitter 15275493907889029131Like on Twitter 15275493907889029131Twitter 1527549390788902913
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

#Aenova Group invests US$11 mln to expand production of highly potent drugs in Germany
https://t.co/cRRWxBANAr #healthtech #innovation #healthcaredelivery #science #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1527546192435064832Retweet on Twitter 1527546192435064832Like on Twitter 1527546192435064832Twitter 1527546192435064832
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

Pollution caused 1 in 6 deaths globally for five years, study says
https://t.co/Wt2uRe1DHA #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #airpollution

Reply on Twitter 1527544485231607808Retweet on Twitter 1527544485231607808Like on Twitter 1527544485231607808Twitter 1527544485231607808
Retweet on TwitterHealthCare Africa Magazine Retweeted
OliveMugendaProf. Olive Mugenda Ph.D MGH@OliveMugenda·
May 18, 2022

The Cath-Lab at KUTRRH is now ready for commissioning. Cath-Lab is a specialised lab that deals with diagnosing blockages within the heart, unblocking as well as performing other interventions like cardiac pacemaker placements.
A great milestone for KUTRRH, MoH and Kenyans.

4
Reply on Twitter 1526921388057051137Retweet on Twitter 152692138805705113727Like on Twitter 1526921388057051137119Twitter 1526921388057051137
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Health and wellness startup @FlexifyMe raises US$300K in seed round
https://t.co/vyCRnHxiil #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #wellness #startup

Reply on Twitter 1526125167860146177Retweet on Twitter 1526125167860146177Like on Twitter 1526125167860146177Twitter 1526125167860146177
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa magazine

Food Business Africa magazine

Food Safety Africa magazine

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.